Global private equity healthcare specialist Archimed announced on October 16 that it has acquired FIM Medical. The company is being acquired by ArchiMed’s latest fund, MED Rise, which closed on €400 million (approximately USD $436 million) in April 2024.
FIM Medical is a prominent company in the French occupational health medical device market. The company is a designer, manufacturer and supplier of medical screening devices. It provides vision, hearing and respiratory care products, using proprietary technology in both its medical devices and software.
ArchiMed is an independent investment firm focused exclusively on healthcare industries. It has directly managed and invested in more than 80 companies with a combined value of $50 billion. Its mix of operational, medical, scientific and financial expertise allows the ArchiMed team to serve as both a strategic and financial partner to European and North American small and middle-market businesses.
FIM Medical was sourced directly by Archimed’s MedTech team, through its neuro and sensory focus. Financial terms of the deal were not disclosed.
“FIM Medical is a valuable addition to the Archimed portfolio, strengthening our presence into the neuro, sensory and occupational Health sectors, which we already know well through our investments in Vita Health, Natus Sensory, Ad-Tech and some others,” said Antoine Faguer, partner at Archimed, in a statement.
According to data captured in the LevinPro HC database, there have been 75 Medical Devices deals announced so far this year. There were 113 Medical Devices deals announced during 2023, and 124 announced during 2022.
